1. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I. F., Bast, R. C., Jr., and Finn, O. J. (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells, Cancer Res., 51, 2908–2916.
2. Berd, D., Maguire, H. C., Jr., McCue, P., and Mastrangelo, M. J. (1990) Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients, J. Clin. Oncol., 8, 1858–1867; doi: 10.1200/JCO.1990.8.11.1858.
3. Ioannides, C. G., Fisk, B., Jerome, K. R., Irimura, T., Wharton, J. T., and Finn, O. J. (1993) Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides, J. Immunol., 151, 3693–3703.
4. Apostolopoulos, V., Pietersz, G. A., and McKenzie, I. F. (1999) MUC1 and breast cancer, Curr. Opin. Mol. Ther., 1, 98–103.
5. Taylor-Papadimitriou, J., Burchell, J., Miles, D. W., and Dalziel, M. (1999) MUC1 and cancer, Biochim. Biophys. Acta, 1455, 301–313; doi: 10.1016/S0925-4439(99)00055-1.